5 learnings from FDA’s new Biocompatibility guidance
In October last year, the FDA published draft guidance regarding the biocompatibility of certain devices that contact intact skin. Our…
Congenius
In October last year, the FDA published draft guidance regarding the biocompatibility of certain devices that contact intact skin. Our…
Congenius
The process of innovation in life sciences is capital intensive – associated with high risk and strict regulations. In this…
Congenius
Our December 2020 MedTech news round up covers the Brexit impact on clinical studies, EC clarification on remote audits, FDA`s update on…
Congenius
Next to take our Consultant Spotlight hot seat is Ivo Dolezal. With over 17 years` experience in MedTech, Ivo shares…
Congenius
What is the difference between a Traditional, Abbreviated and Special 510(k)? In which scenario should you use each submission type?…
Congenius
Artificial Intelligence is changing the world. In a MedTech context, it enables a small team to affect many lives. To…
Congenius
The responsible implementation of Artificial Intelligence within MedTech will transform the efficiency of the industry. But which areas within medical…
Congenius
At Congenius, we are committed to facilitating healthier lives, be that through our consultancy work in medical devices, or via…
Congenius